Summit Therapeutics Ownership | Who Owns Summit Therapeutics?

Overview ForecastFinancials Chart Transcripts

Summit Therapeutics Ownership Summary

Summit Therapeutics is owned by 11.85% institutional investors, 84.36% insiders, and 3.79% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 3.36% of SMMT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.47% of its assets in Summit Therapeutics shares.

SMMT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Summit Therapeutics	11.85%	84.36%	3.79%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Baker bros. advisors lp	24.42M	3.36%	$435.86M
Vanguard group	11.67M	1.61%	$208.26M
Blackrock funding, inc. /de	8.43M	1.16%	$150.46M
Blackrock	7.90M	1.13%	$61.61M
Fmr	8.06M	1.11%	$143.75M
Price t rowe associates inc /md/	6.56M	0.90%	$117.00M
State street	4.12M	0.59%	$32.16M
Geode capital management	3.20M	0.44%	$57.13M
Millennium management	2.05M	0.28%	$36.58M
Charles schwab investment management	1.49M	0.20%	$26.50M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Baker bros. advisors lp	24.42M	4.66%	$435.86M
Superstring capital management lp	164.56K	2.54%	$2.94M
Exome asset management	130.41K	1.75%	$2.33M
Ivyrock asset management (hk)	166.50K	1.31%	$2.97M
Wealth management partners	97.38K	0.75%	$1.74M
Rock springs capital management lp	1.05M	0.72%	$18.81M
Jgp global gestao de recursos ltda.	17.08K	0.69%	$304.79M
Healthinvest partners ab	101.18K	0.62%	$1.31M
Qvt financial lp	360.52K	0.57%	$6.43M
Sectoral asset management	30.00K	0.36%	$535.35K

Top Buyers

Holder	Shares	% Assets	Change
Price t rowe associates inc /md/	6.56M	0.01%	1.12M
Ubs group	1.19M	0.00%	1.07M
Millennium management	2.05M	0.02%	827.48K
Vanguard group	11.67M	0.00%	724.04K
Pictet asset management sa	1.39M	0.03%	695.84K

Top Sellers

Holder	Shares	% Assets	Change
State street	4.12M	0.00%	-3.99M
Blackrock	7.90M	0.00%	-1.92M
Darwin global management	-	-	-1.08M
Anson funds management lp	-	-	-941.91K
Federated hermes	-	-	-544.88K

New Positions

Holder	Shares	% Assets	Change	Value
Caption management	499.10K	0.06%	499.10K	$3.89M
Bnp paribas arbitrage, snc	493.19K	0.00%	493.19K	$8.80M
Ivyrock asset management (hk)	166.50K	1.31%	166.50K	$2.97M
Superstring capital management lp	164.56K	2.54%	164.56K	$2.94M
Exome asset management	130.41K	1.75%	130.41K	$2.33M

Sold Out

Holder	Change
Citadel advisors	-5.00
Signaturefd	-21.00
Capital performance advisors llp	-36.00
Reuter james wealth management	-312.00
Global retirement partners	-500.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	208	9.47%	86,084,916	1.94%	11	8.77%	131	12.93%	39	11.43%
Sep 30, 2024	189	43.18%	84,448,625	17.02%	11	11.18%	115	79.69%	35	-23.91%
Jun 30, 2024	131	23.58%	72,166,501	45.37%	10	16.02%	64	10.34%	45	73.08%
Mar 31, 2024	106	9.28%	49,642,039	54.58%	8	37.82%	58	28.89%	26	36.84%
Dec 31, 2023	97	3.19%	32,113,817	-0.21%	4	21.63%	45	7.14%	19	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	3.49M	0.47%	24.61K
Vanguard US Total Market Shares ETF	3.43M	0.46%	-167.64K
Vanguard Small Cap Index	2.82M	0.38%	2.33K
SPDR® S&P Biotech ETF	2.81M	0.38%	-30.16K
iShares Russell 2000 ETF	2.42M	0.33%	-20.95K
Fidelity Select Biotechnology	2.29M	0.31%	-283.40K
Fidelity Growth Compy Commingled Pl S	2.15M	0.29%	290.50K
Vanguard Institutional Extnd Mkt Idx Tr	2.13M	0.29%	2.99K
Vanguard Small Cap Value Index Inv	1.86M	0.25%	-6.87K
Fidelity Growth Company Fund	1.67M	0.23%	340.10K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 27, 2024	Zanganeh Mahkam	Chief Executive Officer	Buy	$127.67K
Mar 27, 2024	Zanganeh Mahkam	Chief Executive Officer	Buy	$74.20K
Mar 26, 2024	Zanganeh Mahkam	Chief Executive Officer	Buy	$112.50K
Mar 27, 2024	Zanganeh Mahkam	Chief Executive Officer	Buy	$96.72K
Mar 26, 2024	Dhingra Ankur	Chief Financial Officer	Buy	$375.00K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-

SMMT Ownership FAQ

Who Owns Summit Therapeutics?

Summit Therapeutics shareholders are primarily institutional investors at 11.85%, followed by 84.36% insiders and 3.79% retail investors. The average institutional ownership in Summit Therapeutics's industry, Biotech Stocks , is 68.48%, which Summit Therapeutics falls below.

Who owns the most shares of Summit Therapeutics?

Summit Therapeutics’s largest shareholders are Baker bros. advisors lp (24.42M shares, 3.36%), Vanguard group (11.67M shares, 1.61%), and Blackrock funding, inc. /de (8.43M shares, 1.16%). Together, they hold 6.13% of Summit Therapeutics’s total shares outstanding.

Does Blackrock own Summit Therapeutics?

Yes, BlackRock owns 1.13% of Summit Therapeutics, totaling 7.9M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 61.61M$. In the last quarter, BlackRock decreased its holdings by -1.925M shares, a -19.59% change.

Who is Summit Therapeutics’s biggest shareholder by percentage of total assets invested?

Baker bros. advisors lp is Summit Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.66% of its assets in 24.42M Summit Therapeutics shares, valued at 435.86M$.

Who is the top mutual fund holder of Summit Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Summit Therapeutics shares, with 0.47% of its total shares outstanding invested in 3.49M Summit Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools